This site is intended for health professionals only

Published on 8 December 2011

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
More deaths “linked” to superbug
Safe preparation of methotrexate syringe outside a centralised cytotoxic preparation unit
Antiplatelet drug unhelpful in haemodialysis
Cytotoxic handling – where are we today?
Targeted therapy in breast cancer

Botulinum toxin A: practice recommendations in France

teaser

Maryvonne Villart, Delphine Pozzi, Kamel Hamami

University Hospital

Raymond Poincar



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Merck agrees huge Vioxx settlement
4
Janssen-Cilag’s Stelara approved by NICE
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Hope of MRSA drug breakthrough
Pixantrone designated orphan drug
Halaven® available in Italy for breast cancer
A day in the life of a compounding pharmacist
Roche to buy Memory Pharmaceuticals